Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Quick Links

Call customer care

Healthcare provider consulting with patient using tablet.

A new era in weight loss management

Introducing Endura Weight Loss Solutions

Patients living with obesity face many challenges on their weight loss journey – from making diet, exercise, and lifestyle changes to managing the ups and downs of their physical, mental, and emotional health. It’s a journey that requires real endurance.

Boston Scientific understands these challenges for your patients, and we offer a new approach to endobariatrics that provides innovative endoscopic options for gastroenterologists. Minimally invasive procedures. Proven, effective results. Endura Weight Loss Solutions. The future of weight loss is here.

null

Endoscopic sleeve gastroplasty (ESG)

Significantly reduce your patient’s stomach volume to help them feel fuller faster. ESG has been shown to provide lasting results when combined with diet and exercise changes.1

null

Transoral outlet reduction (TORe)

Revise a Roux-en-Y gastric bypass to reduce the size of the gastrojejunal outlet as well as the gastric pouch opening. This procedure helps induce satiety for patients.2

null

Intragastric balloon

Temporarily place a balloon in your patient’s stomach to encourage portion control and lifestyle and behavior modification.3

1. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective, multicentre, randomised trial. Lancet. 2022;400:441–451.
1. Jirapinyo P, Kumar N, AlSamman MA, Thompson CC. Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc. 2019;91:1067–1073.
3. US FDA Pivotal Study. n = 137 Orbera, n = 136 control, p < 0.001. Most of the patients from the US FDA pivotal study were female and Caucasian. Because of this, data from this study may not accurately represent the same effectiveness and safety profile in Hispanic, African American, or other ethnic populations.
woman smiling at doctor.

Access physician resources and tools

Download materials from the Patient Education Kit to help your patients become well equipped with the information they need to continue on their weight loss journey. It includes educational content about our weight loss solutions, including patient testimonials, procedural images, and patient brochures.

Hone your skills

See the latest case studies and available training on EDUCARE.

Get updates on Endura Weight Loss Solutions

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

As a condition of the FDA De Novo Authorization of the Overstitch NXT and Overstitch Endoscopic Suturing System for endobariatric procedures (formerly referred to as the Apollo ESG and Apollo REVISE Systems), the devices should only be used for Endoscopic Sleeve Gastroplasty (ESG) or to enable transoral outlet reduction (TORe) as a bariatric revision procedure by gastroenterologists and surgeons who have undergone specific training by the device manufacturer.

To fulfill the FDA requirement and special controls for these devices, Boston Scientific is required to independently host courses with consistent training curricula. More information regarding the referenced ESG and TORe revision procedure training courses is available through Boston Scientific.